Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11958999rdf:typepubmed:Citationlld:pubmed
pubmed-article:11958999lifeskim:mentionsumls-concept:C0003308lld:lifeskim
pubmed-article:11958999lifeskim:mentionsumls-concept:C0030020lld:lifeskim
pubmed-article:11958999lifeskim:mentionsumls-concept:C0762202lld:lifeskim
pubmed-article:11958999lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:11958999pubmed:issue6lld:pubmed
pubmed-article:11958999pubmed:dateCreated2002-4-17lld:pubmed
pubmed-article:11958999pubmed:abstractTextOxime derivatives of the sordarin aglycone have been identified as potent antifungal agents. The in vitro spectrum of activity includes coverage against Candida albicans and Candida glabrata with MICs as low as 0.06 microg/mL. The antifungal activity was established to be exquisitely sensitive to the spatial orientation of the lipophilic side chains.lld:pubmed
pubmed-article:11958999pubmed:languageenglld:pubmed
pubmed-article:11958999pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958999pubmed:citationSubsetIMlld:pubmed
pubmed-article:11958999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958999pubmed:statusMEDLINElld:pubmed
pubmed-article:11958999pubmed:monthMarlld:pubmed
pubmed-article:11958999pubmed:issn0960-894Xlld:pubmed
pubmed-article:11958999pubmed:authorpubmed-author:BarrettJohn...lld:pubmed
pubmed-article:11958999pubmed:authorpubmed-author:Serrano-WuMic...lld:pubmed
pubmed-article:11958999pubmed:authorpubmed-author:St ...lld:pubmed
pubmed-article:11958999pubmed:authorpubmed-author:MazzuccoCharl...lld:pubmed
pubmed-article:11958999pubmed:authorpubmed-author:StickleTerry...lld:pubmed
pubmed-article:11958999pubmed:authorpubmed-author:VyasDolatrai...lld:pubmed
pubmed-article:11958999pubmed:authorpubmed-author:Balasubramani...lld:pubmed
pubmed-article:11958999pubmed:issnTypePrintlld:pubmed
pubmed-article:11958999pubmed:day25lld:pubmed
pubmed-article:11958999pubmed:volume12lld:pubmed
pubmed-article:11958999pubmed:ownerNLMlld:pubmed
pubmed-article:11958999pubmed:authorsCompleteYlld:pubmed
pubmed-article:11958999pubmed:pagination943-6lld:pubmed
pubmed-article:11958999pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:11958999pubmed:meshHeadingpubmed-meshheading:11958999...lld:pubmed
pubmed-article:11958999pubmed:meshHeadingpubmed-meshheading:11958999...lld:pubmed
pubmed-article:11958999pubmed:meshHeadingpubmed-meshheading:11958999...lld:pubmed
pubmed-article:11958999pubmed:meshHeadingpubmed-meshheading:11958999...lld:pubmed
pubmed-article:11958999pubmed:meshHeadingpubmed-meshheading:11958999...lld:pubmed
pubmed-article:11958999pubmed:meshHeadingpubmed-meshheading:11958999...lld:pubmed
pubmed-article:11958999pubmed:meshHeadingpubmed-meshheading:11958999...lld:pubmed
pubmed-article:11958999pubmed:year2002lld:pubmed
pubmed-article:11958999pubmed:articleTitleOxime derivatives of sordaricin as potent antifungal agents.lld:pubmed
pubmed-article:11958999pubmed:affiliationBristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA. michael.serrano-wu@bms.comlld:pubmed
pubmed-article:11958999pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11958999lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11958999lld:pubmed